Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA
Abstract Hepatic fibrosis is a spontaneous wound-healing response triggered by chronic liver injury. Pien Tze Huang (PZH), a traditional Chinese herbal medicine, has been widely used to treat various hepatic diseases in Asia. We used a CCl4-induced mouse model to establish a PZH group of hepatic fib...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69d4a9e5f2e24b0eabdb7c1263263085 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:69d4a9e5f2e24b0eabdb7c1263263085 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:69d4a9e5f2e24b0eabdb7c12632630852021-12-02T18:51:52ZTarget identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA10.1038/s41598-021-96459-52045-2322https://doaj.org/article/69d4a9e5f2e24b0eabdb7c12632630852021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96459-5https://doaj.org/toc/2045-2322Abstract Hepatic fibrosis is a spontaneous wound-healing response triggered by chronic liver injury. Pien Tze Huang (PZH), a traditional Chinese herbal medicine, has been widely used to treat various hepatic diseases in Asia. We used a CCl4-induced mouse model to establish a PZH group of hepatic fibrosis mice treated with PZH and a control group of hepatic fibrosis mice without any treatment. We performed RNA-seq and mass spectrometry sequencing to investigate the mechanism of the PZH response in hepatic fibrosis and identified multiple differentially expressed transcripts (DETs) and proteins (DEPs) that may be drug targets of PZH. Liver functional indices, including serum albumin (ALB), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), were significantly decreased in the PZH treatment group (P < 0.05) in the eighth week. Hematoxylin–eosin (HE), Masson and Sirius red staining demonstrated that PZH significantly inhibited infiltration of inflammatory cells and collagen deposition. A total of 928 transcripts and 138 proteins were differentially expressed in PZH-treated mice compared to the control group. Gene Ontology (GO) enrichment analysis suggested that PZH may alleviate liver injury and fibrosis by enhancing the immune process. Taken together, our results revealed that multiple DETs and DEPs may serve as drug targets of PZH in hepatic fibrosis patient in future clinical practice.Jinhang ZhuDi ZhangTing WangZhiliang ChenLuan ChenHao WuCong HuaiJing SunNa ZhangMuyun WeiFei HongShengying QinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Jinhang Zhu Di Zhang Ting Wang Zhiliang Chen Luan Chen Hao Wu Cong Huai Jing Sun Na Zhang Muyun Wei Fei Hong Shengying Qin Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA |
description |
Abstract Hepatic fibrosis is a spontaneous wound-healing response triggered by chronic liver injury. Pien Tze Huang (PZH), a traditional Chinese herbal medicine, has been widely used to treat various hepatic diseases in Asia. We used a CCl4-induced mouse model to establish a PZH group of hepatic fibrosis mice treated with PZH and a control group of hepatic fibrosis mice without any treatment. We performed RNA-seq and mass spectrometry sequencing to investigate the mechanism of the PZH response in hepatic fibrosis and identified multiple differentially expressed transcripts (DETs) and proteins (DEPs) that may be drug targets of PZH. Liver functional indices, including serum albumin (ALB), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), were significantly decreased in the PZH treatment group (P < 0.05) in the eighth week. Hematoxylin–eosin (HE), Masson and Sirius red staining demonstrated that PZH significantly inhibited infiltration of inflammatory cells and collagen deposition. A total of 928 transcripts and 138 proteins were differentially expressed in PZH-treated mice compared to the control group. Gene Ontology (GO) enrichment analysis suggested that PZH may alleviate liver injury and fibrosis by enhancing the immune process. Taken together, our results revealed that multiple DETs and DEPs may serve as drug targets of PZH in hepatic fibrosis patient in future clinical practice. |
format |
article |
author |
Jinhang Zhu Di Zhang Ting Wang Zhiliang Chen Luan Chen Hao Wu Cong Huai Jing Sun Na Zhang Muyun Wei Fei Hong Shengying Qin |
author_facet |
Jinhang Zhu Di Zhang Ting Wang Zhiliang Chen Luan Chen Hao Wu Cong Huai Jing Sun Na Zhang Muyun Wei Fei Hong Shengying Qin |
author_sort |
Jinhang Zhu |
title |
Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA |
title_short |
Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA |
title_full |
Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA |
title_fullStr |
Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA |
title_full_unstemmed |
Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA |
title_sort |
target identification of hepatic fibrosis using pien tze huang based on mrna and lncrna |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/69d4a9e5f2e24b0eabdb7c1263263085 |
work_keys_str_mv |
AT jinhangzhu targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT dizhang targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT tingwang targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT zhiliangchen targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT luanchen targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT haowu targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT conghuai targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT jingsun targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT nazhang targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT muyunwei targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT feihong targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna AT shengyingqin targetidentificationofhepaticfibrosisusingpientzehuangbasedonmrnaandlncrna |
_version_ |
1718377389328695296 |